Rabies Vaccine Suppliers & Bulk Manufacturers
Available Forms: Lyophilized powder, Pre-filled syringes
Available Strengths: 1 mL doses
Reference Brands: Imovax Rabies(US)
Category:
Vaccines
Rabies vaccine stimulates immunity by introducing inactivated rabies virus, triggering the production of protective antibodies. It effectively prevents rabies infection, especially post-exposure. Benefits include lifelong protection, reducing fatalities, and controlling the spread of this deadly zoonotic disease through pre- and post-exposure prophylaxis.
Rabies Vaccine is available in Lyophilized powder, Pre-filled syringes
and strengths such as 1 mL doses.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Rabies Vaccine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Rabies Vaccine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Rabies vaccines are approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, FDA approval involves rigorous clinical evaluations, while in the EU, CE marking certifies conformity with in vitro diagnostic and medicinal regulations. These vaccines undergo validation, stability testing, and extensive audits, with detailed documentation including safety profiles, clinical trial data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective rabies prophylaxis programs worldwide, essential for travel, post-exposure treatment, and high-risk populations.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing